114 related articles for article (PubMed ID: 1651786)
21. Herpesvirus saimiri-transformed human CD4+ T cells can provide polyclonal B cell help via the CD40 ligand as well as the TNF-alpha pathway and through release of lymphokines.
Saha K; Ware R; Yellin MJ; Chess L; Lowy I
J Immunol; 1996 Nov; 157(9):3876-85. PubMed ID: 8892618
[TBL] [Abstract][Full Text] [Related]
22. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
Splawski JB; Jelinek DF; Lipsky PE
J Immunol; 1989 Mar; 142(5):1569-75. PubMed ID: 2493049
[TBL] [Abstract][Full Text] [Related]
26. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
27. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
Beatty PR; Krams SM; Martinez OM
J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
[TBL] [Abstract][Full Text] [Related]
28. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
Vine JB; Geppert TD; Lipsky PE
J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
[TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
30. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
Condino-Neto A; Newburger PE
Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
[TBL] [Abstract][Full Text] [Related]
31. Human B lymphoma cell line producing B cell growth factor.
Ambrus JL; Fauci AS
J Clin Invest; 1985 Feb; 75(2):732-9. PubMed ID: 2982918
[TBL] [Abstract][Full Text] [Related]
32. Multiple and heterogeneous patterns of cytokine production in 18 leukemia and in vitro transformed mature T cell lines reflect the individuality of human leukemias.
Dao T; Holán V; Minowada J
Int J Hematol; 1993 Apr; 57(2):139-46. PubMed ID: 8494992
[TBL] [Abstract][Full Text] [Related]
33. Human BCGF-12kD functions as an autocrine growth factor in transformed B cells.
Kumar A; Vasquez A; Maizel AL; Sharma S
Eur Cytokine Netw; 1990; 1(2):109-13. PubMed ID: 1966378
[TBL] [Abstract][Full Text] [Related]
34. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
35. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
36. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines.
Lemoine FM; Krystal G; Humphries RK; Eaves CJ
Cancer Res; 1988 Nov; 48(22):6438-43. PubMed ID: 3263188
[TBL] [Abstract][Full Text] [Related]
37. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
Andersson J
Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
40. Human B-cell TNF-beta microheterogeneity.
Benjamin D; Kofler G; Tschachler E
Lymphokine Cytokine Res; 1992 Feb; 11(1):45-54. PubMed ID: 1576246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
